# A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

> **NCT06461208** · PHASE3 · RECRUITING · sponsor: **King's College London** · enrollment: 300 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Encapsulated FMT
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06461208
- **Lead sponsor:** King's College London
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-21
- **Primary completion:** 2028-01-31
- **Final completion:** 2028-06-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-02-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06461208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06461208, "A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06461208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*